Search your stocks

Share

Profile

HESTERBIOHester Biosciences Ltd.

2032.5(-0.24%)

1W: -3.80%

1M: +0.59%

1Y: +40.89%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth of 12% in the latest quarter indicates strong demand.
Net profit surged to ₹8.39 crore, reflecting operational efficiency.
Improved operating margins showcase better cost management.

NEGATIVES

Drop in revenue from ₹82.27 crore to ₹63.22 crore indicates volatility.
Significant decline in other income, impacting overall profitability.
Tax rate spike in the latest quarter reduced net profit margins.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		70.45	66.98	79.25	82.27	83.69	63.22	81.92	84.10
Expenses		69.60	62.77	74.01	73.76	74.62	58.64	72.54	67.28
Operating Profit		0.86	4.21	5.24	8.51	9.07	4.58	9.39	16.82
Other Income		4.36	0.99	4.15	1.23	1.84	7.81	-6.95	2.32
Interest		8.07	2.19	6.94	5.01	5.89	-3.81	5.62	1.81
Depreciation		4.28	3.75	3.74	4.13	4.20	4.29	4.18	4.18
Profit Before Tax		6.76	6.41	9.87	10.59	11.87	13.37	3.75	20.19
Tax		2.72	2.39	3.47	3.11	3.48	1.96	2.20	2.89
Net Profit		4.04	4.02	6.40	7.49	8.39	11.41	1.54	17.30
Eps in Rs		4.75	4.73	7.52	8.80	9.86	13.41	1.82	20.33